Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-08-23
2011-08-23
Skowronek, Karlheinz R (Department: 1613)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C548S217000
Reexamination Certificate
active
08003803
ABSTRACT:
Fused-ring, heterocyclic-substituted tricyclics of the formulaor a pharmaceutically acceptable salt or solvate of said compound, isomer or racemic mixture wherein represents an optional double bond, and wherein An, En, Mn, Gn, Jn, R3, n7, R8, R9, R10, R11, R32, R33, X, Y, B and Het are herein defined and the remaining substituents are as defined in the specification, are disclosed, as well as pharmaceutical compositions containing them and a method of treating diseases associated with thrombosis, atherosclerosis, restenosis, hypertension, angina pectoris, arrhythmia, heart failure, and cancer by administering said compounds. Combination therapy with other cardiovascular agents is also claimed.
REFERENCES:
patent: 6063847 (2000-05-01), Chackalamannil et al.
patent: 6326380 (2001-12-01), Chackalamannil et al.
patent: 6645987 (2003-11-01), Chackalamannil et al.
patent: 7037920 (2006-05-01), Chackalamannil et al.
patent: 7713999 (2010-05-01), Chackalamannil et al.
patent: 2003/0203927 (2003-10-01), Chackalamannil et al.
patent: 2004/0152736 (2004-08-01), Chackalamannil et al.
patent: WO 94/03479 (1994-02-01), None
patent: WO 01/96330 (2001-12-01), None
Christine Espino & J. Du Bois, A Rh-Catalyzed C-H Insertion Reaction for the Oxidative Conversion of Carbamates to Oxazolidinones, 40 Angew. Chem. Intl. Ed.598 (2001).
Bensaid et al “The Cannabinoid CB, Receptor Antagonist SR141716 Increases Acrp30 mRNA Expression in Adipose Tissue of Obese fa/fa Rats and in Cultured Adipocyte Cells”, Molecular Pharmacology, 63(4): 908-91.4 (2003).
Bernatowicz et al., “Development of Potent Thrombin Receptor Antagonist Peptides”,J. Med. Chem., 39: 4879-4887 (1996).
Chackalamannil, “A Highly Efficient Total Synthesis of (+)-Himbacine”,J. Am. Chem. Soc., 118: 9812-9813 (1996).
Pertwee, “Pharmacology of Cannabinoid Receptor Ligands”,Current Medicinal Chemistry, 6(8): 635-664 (1999).
PCT International Search Report dated Jan. 2, 2008 for PCT Application No. PCT/US2007/008978.
Chackalamannil, et al., Journal of Medicinal Chemistry, (2005), pp. 5884-5887, vol. 48, No. 19.
Chackalamannil Samuel
Xia Yan
Basquill Sean
Russell Mark W.
Schering Corporation
Skowronek Karlheinz R
LandOfFree
Fused ring thrombin receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fused ring thrombin receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fused ring thrombin receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2618784